Non-symmetric porphyrins encapsulated in liposomes: Tumor cell destruction via non-photodynamic activity
Source abstract
Abstract
Abstract Two non-symmetric free-base porphyrins, one with an electron density withdrawing group (–NO2), H2(NPTPP), and the other with an electron density donor group (–NH2), H2(APTPP), were synthesized, characterized and the photophysical properties reported. The compound H2(APTPP) showed a fluorescence quantum yield (ΦFl = 0.12) similar to that of H2(TPP), and this derivative showed the longer lifetime in the singlet state (τ1 = 1.51 ns and τ2 = 7.74 ns; bi-exponential process) and the ability to generate singlet oxygen. It also showed relative resistance to the photobleaching process. However, it presented a high degree of aggregation in a medium that mimicked the biological one. In cell viability tests against B16–F10 cells, H2(APTPP) did not show cytotoxic activity either in absence or presence of a light stimulus. H2(NPTPP) at 50 μM showed a reduction in cell viability (of up to 50%) under dark or light conditions. The liposomal formulation containing H2(APTPP) was stable for 2 h and caused the death of tumor cells (up to 95%) even in absence of light stimulus, showing that cell death is associated with non-photodynamic processes.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Porphyrin and Phthalocyanine Chemistry · Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (59)
Show source-provided references
1. Structure and function of heme proteins regulated by diverse post-translational modifications10.1016/j.abb.2018.01.009 ↗
2. Recent progress on exploring μ-oxo bridged binuclear porphyrinoid complexes in catalysis and material science10.1016/j.ccr.2019.03.016 ↗
3. Optically active porphyrin and phthalocyanine systems10.1021/acs.chemrev.5b00588 ↗
4. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential10.1089/ars.2009.2876 ↗
5. SOD-like activity of Mn(II) β-octabromo-meso-tetrakis(N-methylpyridinium-3-yl)porphyrin equals that of the enzyme itself10.1016/j.abb.2008.04.032 ↗
6. Selective functionalisation of saturated C–H bonds with metalloporphyrin catalysts10.1039/c0cs00142b ↗
7. Biomimetic oxidation of cyclic and linear alkanes: high alcohol selectivity promoted by a novel manganese porphyrin catalyst10.1039/C6NJ03072F ↗
8. Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications10.1002/lsm.20361 ↗
9. Advanced photosensitizer activation strategies for smarter photodynamic therapy beacons10.1002/anie.201805246 ↗
10. Cancer, photodynamic therapy and porphyrin-type derivatives10.1590/0001-3765201820170811 ↗
11. Photochemotherapeutic strategy against Acanthamoeba infections10.1128/AAC.05126-14 ↗
12. Photodynamic effect of zinc porphyrin on the promastigote and amastigote forms of: Leishmania braziliensis10.1039/c7pp00458c ↗
13. Current states and future views in photodynamic therapy10.1016/j.jphotochemrev.2011.06.001 ↗
14. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
15. Mechanisms in photodynamic therapy: Part one - photosensitizers, photochemistry and cellular localization10.1016/S1572-1000(05)00007-4 ↗
16. Photosensitizers in clinical PDT10.1016/S1572-1000(04)00007-9 ↗
17. Photodynamic and non-photodynamic action of several porphyrins on the activity of some heme-enzymes
18. Toward a molecular understanding of the photosensitizer-copper interaction for tumor destruction10.1007/s12551-013-0112-4 ↗
19. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy10.1111/j.1751-1097.2009.00585.x ↗
20. Self-aggregation of free base porphyrins in aqueous solution and in DMPC vesicles10.1016/j.bpc.2007.11.007 ↗
21. New developments in liposomal drug delivery10.1021/acs.chemrev.5b00046 ↗
22. Synthesis, characterization and photodynamic activity against bladder cancer cells of novel triazole-porphyrin derivatives10.3390/molecules25071607 ↗
23. Cerasome as an infusible, cell-friendly, and serum-compatible transfection agent in a viral size10.1021/ja058016i ↗
24. Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: nanodispersions of liquid-crystalline phase as nanocarriers10.1016/j.ejps.2015.12.003 ↗
25. Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy10.1016/j.biomaterials.2019.119707 ↗
26. Synthesis and reactions of meso-(p-nitrophenyl)porphyrins10.1016/j.tet.2004.01.080 ↗
27. New manganese porphyrin as biomimetic catalyst of cyclohexane oxidation: effect of water or imidazole as additives10.1016/j.apcata.2013.09.033 ↗
28. Photophysical and photochemical properties of potential porphyrin and chlorin photosensitizers for PDT10.1016/1011-1344(95)07241-1 ↗
29. Demasa · 1971 · vol. 75
30. pH and charge effects behind the interaction of artepillin C, the major component of green propolis, with amphiphilic aggregates: optical absorption and fluorescence spectroscopy studies10.1111/php.13128 ↗
31. Photosensitized singlet oxygen and its applications10.1016/S0010-8545(02)00034-6 ↗
32. Liposome: classification, preparation, and applications10.1186/1556-276X-8-102 ↗
33. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗
34. Study of the effects of substitution on the absorption spectra of porphin10.1063/1.1730148 ↗
35. Theoretical study of novel porphyrins bearing electron donor-acceptor groups10.1002/qua.24316 ↗
36. Design and synthesis of new porphyrin analogues as potent photosensitizers for photodynamic therapy: spectroscopic approach10.1007/s10895-020-02513-2 ↗
37. UV-visible, fluorescence and EPR properties of porphyrins and metalloporphyrins10.1016/j.dyepig.2007.04.007 ↗
38. Knyukshto · 1999 · vol. 304
39. A structural model of nitro-porphyrin dyes based on spectroscopy and density functional theory10.1002/jcc.24887 ↗
40. Studying the intersystem crossing rate and triplet quantum yield of meso-substituted porphyrins by means of pulse train fluorescence technique10.1142/S1088424616500048 ↗
41. Spectroscopic, photophysical, and redox properties of some meso-substituted free-base porphyrins10.1021/j100129a017 ↗
42. Spectroscopic, redox and photophysical properties of push-pull Ñuoroarylporphyrins10.1039/a704663d ↗
43. Some misconceptions concerning the electronic spectra of tri-positive europium and cerium10.1039/c3cs60033e ↗
44. Application of the electronic spectra of porphyrins for analytical purposes: the effects of metal ions and structural distortions10.1016/j.microc.2012.07.002 ↗
45. The excitation wavelength dependent fluorescence of porphyrins10.1016/j.cplett.2008.02.012 ↗
46. Activatable photosensitizers for imaging and therapy10.1021/cr900236h ↗
47. The photostability and fluorescence properties of diphenylisobenzofuran10.1016/j.jlumin.2011.05.048 ↗
48. Chalcogenapyrylium dyes as potential photochemotherapeutic agents. Solution studies of heavy atom effects on triplet yields, quantum efficiencies of singlet oxygen generation, rates of reaction with singlet oxygen, and emission quantum yields10.1021/ja00166a019 ↗
49. Determination of singlet oxygen quantum yields with 1,3-diphenylisobenzofuran in model membrane systems10.1016/0165-022X(93)90058-V ↗
50. The challenging combination of intense fluorescence and high singlet oxygen quantum yield in photostable chlorins-a contribution to theranostics10.1039/c3pp25419d ↗
51. A compilation of singlet oxygen yields from biologically relevant molecules10.1111/j.1751-1097.1999.tb08240.x ↗
52. Aggregation properties of nitroporphyrins: comparisons between solid-state and solution structures10.1021/ic00066a027 ↗
53. Synthesis of 2,7,12,17-tetraaryl-3,8,13,18-tetranitroporphyrins; electronic effects on aggregation properties of porphyrins10.1039/a805471a ↗
54. From self-assembly to noncovalent synthesis of programmable porphyrins' arrays in aqueous solution10.1039/c2cc31856c ↗
55. J- and H-aggregates of Porphyrin−Surfactant complexes: time-resolved fluorescence and other spectroscopic studies10.1021/jp9723372 ↗
56. J-aggregate formation in bis-(4-carboxyphenyl)porphyrins in water : pH and counterion dependence10.1039/c0nj00201a ↗
57. Self-assembled π-stacks of functional dyes in solution: structural and thermodynamic features10.1039/B809359H ↗
58. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems10.3390/pharmaceutics10020057 ↗
59. Nitro-group-containing drugs10.1021/acs.jmedchem.8b00147 ↗